-
Sector Analysis
B-Cell Non-Hodgkins Lymphoma Cell Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2021-2031
B-Cell Non-Hodgkins Lymphoma Cell Therapy  Market Report Overview The total market value for the 15M, which includes both cell therapies and established/traditional NHL therapies was $16.1 billion in 2021. The market growth will be attributed to the Kymriah, Yescarta, Breyanzi, and Carteyva, which will receive label expansions into earlier lines of therapy and new NHL subtypes. B-Cell Non-Hodgkins Lymphoma Cell Therapy  Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the B-Cell Non-Hodgkins Lymphoma Cell Therapy...
-
Sector Analysis
Colorectal Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2031
Colorectal Cancer Cell and Gene Therapy Market Report Overview The CRC cell and gene therapy market size across the 15MM was $18.9 billion in 2021. The market growth will be attributed to the combination therapy of OVs + ICIs in dMMR/MSI-H patients in 2L and 3L settings. Colorectal Cancer Cell and Gene Therapy Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Colorectal Cancer Cell and Gene Therapy Market Forecast Download A Free Report Sample...
-
Sector Analysis
Acute Myeloid Leukemia Cell Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2031
Acute Myeloid Leukemia Market Report Overview The AML market value for the 15 markets (15M) was $3.1 billion in 2021. Moreover, the high transplant relapse rate and steady increase in incidence provide a steady flow of cell therapy-eligible patients and will drive market growth during the forecast period. Buy Full Report to Know More About the Acute Myeloid Leukemia Market Forecast Download a Free Report Sample The acute myeloid leukemia market research report offers a comprehensive insight into the market...
-
Sector Analysis
EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) – Epidemiology Forecast to 2025
Lung cancer is a disease of uncontrolled cell growth in the lung tissues. It is one of the most commonly occurring cancers in the world (IARC, 2016). Lung cancer is classified into three main types: non-small cell lung cancer (NSCLC), small cell lung cancer, and lung carcinoid tumor. NSCLC is the most common type of lung cancer, making up about 85% of all lung cancers. Small cell lung cancer accounts for 10-15% of lung cancers, while carcinoid tumors are the...
-
Product Insights
Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Recurrent Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Recurrent Malignant Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Synovial Sarcoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Synovial Sarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Synovial Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Synovial Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Thymic Carcinoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Thymic Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Thymic Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Thymic Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Medullary Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Medullary Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Salivary Gland Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Salivary Gland Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Salivary Gland Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.